OTCMKTS:VVCIF VIVO Cannabis (VVCIF) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free VVCIF Stock Alerts $0.02 +0.00 (+4.79%) (As of 04/4/2023) Add Compare Share Share Today's Range$0.0135▼$0.015350-Day Range$0.0153▼$0.015352-Week Range$0.01▼$0.07Volume1,600 shsAverage Volume32,621 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get VIVO Cannabis alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About VIVO Cannabis Stock (OTCMKTS:VVCIF)VIVO Cannabis, Inc. engages in the production and sale of cannabis-based products. It operates through the following segments: Cannabis Sales, Patient Clinics, and Corporate. The Cannabis Sales segment produces and sells cannabis and cannabis-derived products for direct sale to medical patients and for the adult-use market. The Patient Clinics segment operates a portfolio of education focused, patient-centric, and cannabis discovery clinics under the name of Harvest Medicine. The Corporate segment relates to the non-production related corporate activities and international operations. The company was founded by Ken Clement on April 12, 2007 and is headquartered in Napanee, Canada.Read More VVCIF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VVCIF Stock News HeadlinesNovember 30, 2023 | msn.comMerry, stylish Christmas with limited edition rose pink vivo V29 5GJune 20, 2023 | benzinga.comVivo Infusion Acquires Specialty Infusion CentersApril 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.June 19, 2023 | benzinga.comvivo Becomes the Official Exclusive Supplier of Mobile Phones for the 19th Asian Games HangzhouMay 10, 2023 | theglobeandmail.comClosing Bell: Vivo Cannabis Inc flat on Tuesday (VIVO)May 9, 2023 | theglobeandmail.comClosing Bell: Vivo Cannabis Inc flat on Tuesday (VIVO-WT)April 13, 2023 | msn.comMediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30%March 30, 2023 | benzinga.comVIVO Cannabis Stock (OTC:VVCIF), Short Interest ReportApril 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 28, 2023 | benzinga.comVIVO Cannabis FY22 Revenue Stagnates, What About Net Loss?March 28, 2023 | finance.yahoo.comVIVO Cannabis Announces Fourth Quarter 2022 ResultsMarch 22, 2023 | msn.comMediPharm Labs Shareholders Approve Merger With VIVO CannabisMarch 21, 2023 | finance.yahoo.comVIVO Cannabis Announces Approval of Proposed Arrangement at Special Meeting of ShareholdersFebruary 17, 2023 | seekingalpha.comVVCIF VIVO Cannabis Inc.February 17, 2023 | finance.yahoo.comVIVO Cannabis Inc. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with MediPharm Labs Corp.December 22, 2022 | benzinga.comMediPharm Labs To Acquire VIVO CannabisDecember 22, 2022 | finance.yahoo.comIIROC Trading Halt - VIVODecember 22, 2022 | finance.yahoo.comMediPharm Labs Corp. to Acquire VIVO Cannabis Inc.November 15, 2022 | msn.comVivo Cannabis Q3 Revenue Improves 19% YoY Driven By Increased International SalesNovember 15, 2022 | finance.yahoo.comVIVO Cannabis Announces Third Quarter 2022 ResultsOctober 3, 2022 | finance.yahoo.comVIVO Cannabis Announces Third Supplemental Debenture IndentureSeptember 21, 2022 | finanznachrichten.deVIVO Cannabis Inc.: VIVO Cannabis Announces Agreement to Amend Outstanding DebenturesSeptember 19, 2022 | msn.comVIVO Cannabis Signs Agreement To Amend Outstanding DebenturesSeptember 19, 2022 | finance.yahoo.comVIVO Cannabis Announces Agreement to Amend Outstanding DebenturesAugust 17, 2022 | seekingalpha.comVivo Cannabis reports Q2 resultsAugust 16, 2022 | finance.yahoo.comVIVO Cannabis Announces Second Quarter 2022 ResultsJuly 22, 2022 | msn.comVIVO Cannabis Subsidiary Canna Farms Granted Research License By Health CanadaSee More Headlines Receive VVCIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VIVO Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:VVCIF CUSIPN/A CIKN/A Webvivocannabis.com Phone(416) 848-9839FaxN/AEmployees184Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesRaymond LaflammeChairman & Chief Executive OfficerMichael BumbyChief Financial OfficerRicha LoveChief Medical OfficerJoel MallardChief Customer OfficerAndreas SanderPresident-European OperationsKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors VVCIF Stock Analysis - Frequently Asked Questions How have VVCIF shares performed in 2024? VIVO Cannabis' stock was trading at $0.0153 on January 1st, 2024. Since then, VVCIF shares have increased by 0.0% and is now trading at $0.0153. View the best growth stocks for 2024 here. How do I buy shares of VIVO Cannabis? Shares of VVCIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VVCIF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VIVO Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
